Daratumumab-based treatment of monoclonal gammopathy–associated angioedema due to acquired C1-inhibitor deficiency
Daratumumab-based treatment could control severe, treatment-refractory, life-threatening angioedema due to acquired C1-inhibitor deficiency associated with monoclonal gammopathy.
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-11-01
|
| Series: | Journal of Allergy and Clinical Immunology: Global |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772829324001188 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846169341102391296 |
|---|---|
| author | Remy S. Petersen, MD Lauré M. Fijen, MD, PhD Laurens E. Franssen, MD, PhD Josephine M.I. Vos, MD, PhD Danny M. Cohn, MD, PhD |
| author_facet | Remy S. Petersen, MD Lauré M. Fijen, MD, PhD Laurens E. Franssen, MD, PhD Josephine M.I. Vos, MD, PhD Danny M. Cohn, MD, PhD |
| author_sort | Remy S. Petersen, MD |
| collection | DOAJ |
| description | Daratumumab-based treatment could control severe, treatment-refractory, life-threatening angioedema due to acquired C1-inhibitor deficiency associated with monoclonal gammopathy. |
| format | Article |
| id | doaj-art-6c20e97b8c52416c88335adfdabeabe4 |
| institution | Kabale University |
| issn | 2772-8293 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Journal of Allergy and Clinical Immunology: Global |
| spelling | doaj-art-6c20e97b8c52416c88335adfdabeabe42024-11-13T04:30:46ZengElsevierJournal of Allergy and Clinical Immunology: Global2772-82932024-11-0134100322Daratumumab-based treatment of monoclonal gammopathy–associated angioedema due to acquired C1-inhibitor deficiencyRemy S. Petersen, MD0Lauré M. Fijen, MD, PhD1Laurens E. Franssen, MD, PhD2Josephine M.I. Vos, MD, PhD3Danny M. Cohn, MD, PhD4Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands; Corresponding author: Remy S. Petersen, MD, Meibergdreef 9 1105 AZ Amsterdam.Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The NetherlandsDepartment of Hematology, Jeroen Bosch Hospital, Den Bosch, The NetherlandsDepartment of Immunohematology Diagnostics, Sanquin Diagnostic Services, Amsterdam, The Netherlands; Department of Hematology, Cancer Center Amsterdam and Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The NetherlandsDepartment of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The NetherlandsDaratumumab-based treatment could control severe, treatment-refractory, life-threatening angioedema due to acquired C1-inhibitor deficiency associated with monoclonal gammopathy.http://www.sciencedirect.com/science/article/pii/S2772829324001188Acquired C1-inhibitor deficiencyangioedemamonoclonal gammopathyMGUSdaratumumabbradykinin |
| spellingShingle | Remy S. Petersen, MD Lauré M. Fijen, MD, PhD Laurens E. Franssen, MD, PhD Josephine M.I. Vos, MD, PhD Danny M. Cohn, MD, PhD Daratumumab-based treatment of monoclonal gammopathy–associated angioedema due to acquired C1-inhibitor deficiency Journal of Allergy and Clinical Immunology: Global Acquired C1-inhibitor deficiency angioedema monoclonal gammopathy MGUS daratumumab bradykinin |
| title | Daratumumab-based treatment of monoclonal gammopathy–associated angioedema due to acquired C1-inhibitor deficiency |
| title_full | Daratumumab-based treatment of monoclonal gammopathy–associated angioedema due to acquired C1-inhibitor deficiency |
| title_fullStr | Daratumumab-based treatment of monoclonal gammopathy–associated angioedema due to acquired C1-inhibitor deficiency |
| title_full_unstemmed | Daratumumab-based treatment of monoclonal gammopathy–associated angioedema due to acquired C1-inhibitor deficiency |
| title_short | Daratumumab-based treatment of monoclonal gammopathy–associated angioedema due to acquired C1-inhibitor deficiency |
| title_sort | daratumumab based treatment of monoclonal gammopathy associated angioedema due to acquired c1 inhibitor deficiency |
| topic | Acquired C1-inhibitor deficiency angioedema monoclonal gammopathy MGUS daratumumab bradykinin |
| url | http://www.sciencedirect.com/science/article/pii/S2772829324001188 |
| work_keys_str_mv | AT remyspetersenmd daratumumabbasedtreatmentofmonoclonalgammopathyassociatedangioedemaduetoacquiredc1inhibitordeficiency AT lauremfijenmdphd daratumumabbasedtreatmentofmonoclonalgammopathyassociatedangioedemaduetoacquiredc1inhibitordeficiency AT laurensefranssenmdphd daratumumabbasedtreatmentofmonoclonalgammopathyassociatedangioedemaduetoacquiredc1inhibitordeficiency AT josephinemivosmdphd daratumumabbasedtreatmentofmonoclonalgammopathyassociatedangioedemaduetoacquiredc1inhibitordeficiency AT dannymcohnmdphd daratumumabbasedtreatmentofmonoclonalgammopathyassociatedangioedemaduetoacquiredc1inhibitordeficiency |